-
Published 3/31/2026
Tronieri JS, Kushner RF, Apovian CM, Fitch A, Still C, Wadden TA. Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis. Obesity (Silver Spring). 2026 May; 34(5):1010-1019. PMID: 41914839.
-
Published 3/19/2026
Chang R, Redman LM, Ravussin E, Apovian CM, Ostrominski JW. Effect of Caloric Restriction on Predicted Risk of Incident Cardiovascular Disease and Type 2 Diabetes in Young Adults: Findings From the CALERIE 2 Trial. Diabetes Obes Metab. 2026 Jun; 28(6):5374-5378. PMID: 41852238.
-
Published 3/17/2026
Wills MV, Lee S, Mocanu V, Lee Y, Kachornvitaya P, Zhu X, Alfaris N, Andromalos L, Apovian C, Behrens E, Birk D, Busetto L, Courcoulas A, Cummings D, Faria SL, Ghanem O, Han SM, Karmali S, Kaplan L, Kow L, le Roux CW, Mahawar K, Gawdat K, Munoz R, Musella M, Nimeri A, O'Kane M, Palermo M, Ponce de Leon Ballesteros G, Salminen P, Sullivan S, Udomsawaengsup S, Tewksbury C, Vidal J, Wilding J, Dang J, Strong A, Navarrete S, Zundel N, Kermansaravi M, Butsch S, Kroh M, Corcelles R. International expert consensus on definitions and management of weight recurrence and suboptimal response after metabolic and bariatric surgery: a Delphi study. Surg Obes Relat Dis. 2026 Mar 17. PMID: 41963214.
-
Published 11/25/2025
Chang R, Claggett BL, Redman LM, Ravussin E, Apovian CM, Ostrominski JW. Effect of caloric restriction on cardiovascular-kidney-metabolic health in young adults: A secondary analysis of the randomised CALERIE trial. Diabetes Obes Metab. 2026 Feb; 28(2):1565-1568. PMID: 41287557.
-
Published 11/7/2025
Thompson CC, Jirapinyo P, McCarty TR, Brethauer S, Shaheen N, Sullivan SA, Koch T, Reavis KM, Abu Dayyeh BK, Wilson EB, Schulman AR, Butsch WS, Gersin KS, Apovian CM, Schauer P. A Multicenter Double-blind Randomized Sham-controlled Trial Assessing the EndoBarrier Duodenal-jejunal Bypass Liner for the Treatment of Poorly Controlled type 2 Diabetes Mellitus with Concomitant Obesity: The ENDO Trial. Ann Surg. 2025 Nov 07. PMID: 41199626.